> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Micronor Not Withdrawn Over Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/micronor-not-withdrawn-over-safety-efficacy-fda/
- Published: 2022-06-30T12:00:00.000Z
- Updated: 2026-09-14T17:50:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152210

*Federal Register* notice: FDA has determined that Janssen Pharmaceuticals’ Micronor (norethindrone tablets), indicated for preventing pregnancy, was not withdrawn for reasons of safety or effectiveness. The determination will allow FDA to approve ANDAs that reference this product if all other legal and regulatory requirements are met. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-06-30/pdf/2022-13958.pdf?ref=fdaweb.com).